ImmuneOnco Biopharmaceuticals Has Received A Near-Term Payment Of $5M From Instil Bio's SynBioTx, Bringing The Total Received Under Their License And Collaboration Agreement To $15M, With Potential Future Payments Up To $35M Expected
Portfolio Pulse from Benzinga Newsdesk
ImmuneOnco Biopharmaceuticals has received a $5M payment from Instil Bio's SynBioTx, totaling $15M under their agreement, with potential future payments up to $35M.
September 11, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Instil Bio's SynBioTx has made a $5M payment to ImmuneOnco Biopharmaceuticals, bringing total payments to $15M under their collaboration, with potential for $35M.
The payment from SynBioTx to ImmuneOnco indicates progress in their collaboration, which could lead to further payments and potential revenue growth for Instil Bio. This is likely to positively impact TIL's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80